Shockwave Medical to Participate in Two Upcoming Investor Conferences

SANTA CLARA, Calif., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company will be participating in two upcoming virtual investor conferences:

• The 2022 Wells Fargo Healthcare Conference
  Fireside Chat on Thursday, September 8, 2022, at 9:45 a.m. Eastern Time.

• The Morgan Stanley 20th Annual Global Healthcare Conference
  Fireside Chat on Tuesday, September 13, 2022, at 2:05 p.m. Eastern Time.

Interested parties may access live and archived webcasts of the events on the “Investors” section of the company’s website at: https://ir.shockwavemedical.com.

About Shockwave Medical, Inc.

Shockwave is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.

Media Contact:
Scott Shadiow
+1.317.432.9210
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
dkaster@shockwavemedical.com

Source: Shockwave Medical, Inc.